# Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and Children

> **NCT00484809** · — · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 100 (—)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Enbrel (Etanercept)

## Key facts

- **NCT ID:** NCT00484809
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2006-02
- **Target enrollment:** 100 (—)
- **Last updated:** 2007-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00484809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00484809, "Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and Children". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00484809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*